Published by Josh White on 21st September 2023
(Sharecast News) - Cancer immunotherapy-focussed biopharmaceutical firm Faron Pharmaceuticals named Dr Birge Berns as its interim chief medical officer on Thursday, with the transition becoming effective on 22 September, with Dr Berns operating from the UK.
URL: http://www.digitallook.com/dl/news/story/33786308/...